TRANSCRIPT

Q2 2021 — Earnings call remarks

Q2 2021PDF · 9 pages155 KB
1
Earnings Conference Call
Second Quarter 2021 Remarks
07.15.2021
Moderator
Good morning, and welcome to the UnitedHealth Group Second Quarter 2021 Earnings
Conference Call. A question and answer session will follow UnitedHealth Group’s prepared
remarks. As a reminder, this call is being recorded.
Here is some important introductory information. This call contains “forward-looking” statements
under U.S. federal securities laws. These statements are subject to risks and uncertainties that
could cause actual results to differ materially from historical experience or present expectations.
A description of some of the risks and uncertainties can be found in the reports that we file with
the Securities and Exchange Commission, including the cautionary statements included in our
current and periodic filings.
This call will also reference non-GAAP amounts. A reconciliation of the non-GAAP to GAAP
amounts is available on the “Financial & Earnings Reports” section of the Company’s Investor
Relations page at www.unitedhealthgroup.com.
Information presented on this call is contained in the Earnings Release we issued this morning
and in our Form 8-K dated July 15, 2021, which may be accessed from the Investor Relations
page of the Company’s website. I will now turn the conference over to the chief executive
officer of UnitedHealth Group, Andrew Witty.
Andrew Witty
Good morning and thank you for joining us. As we discuss our enterprise today, I hope
you sense its growing momentum as we advance on our path of improving the quality,
cost and experience of health care for everyone we serve.
Both Optum and UnitedHealthcare grew and delivered on our long-standing strategy
and we have increased our outlook for the year to a range of $18.30 to $18.80 per
share.

-- 1 of 9 --

2
We continue to prioritize three key themes that we believe will underpin the next era of
growth for our enterprise:
• First, unlock the collaborative opportunities within and between Optum and
UnitedHealthcare.
• Second, increasingly apply technology to improve patient care and experience and
to help the system run better.
• And third, strengthen our consumer focus, capabilities and value.
During the quarter we accelerated our efforts to develop and deploy new and innovative
products — informed by the insights of both Optum and UnitedHealthcare — in areas
such as oncology care delivery, rare disease drug management, Optum Virtual, Optum
Financial Services and many others. We are doubling down on efforts to both expand
and link services where it creates value for consumers and patients … to make their
health care journey easier, simpler and more intuitive.
We constantly challenge ourselves to develop capabilities which lead to improved care,
better value and a simpler system. Our sales to clients and partners across all parts of
the health system demonstrate the strong relevance of our innovation. And the
strengthening of our sales pipeline is a key opportunity as we emerge from the COVID
market pause.
A good example of bringing our collective strengths together at scale is the Optum
home and community care platform, through which we care for nearly 10 million people.
This platform includes:
• Our well-known HouseCalls service.
• Comprehensive post-acute care for smoother transitions to home.
• And integrated primary and behavioral care for Medicare Advantage patients
who prefer to receive their care at home.

-- 2 of 9 --

3
Home and community platform services can reduce post-acute medical care costs by a
quarter, unnecessary readmissions by up to a fifth, and hospital admissions by up to
25%.
In Medicaid, we are addressing consumer needs by expanding our long-term
collaboration with public housing authorities, working with government agencies and
community-based organizations to identify and address specific health care issues for
people who are hard to reach and support.
In just the past six months, we have introduced new partnerships in over 20
communities to close gaps in care and address health equity challenges. Using data
and analytics capabilities, we’re able to rapidly identify local health trends and gaps and
then work with community partners to inform guidelines, training materials, processes
and create better tools to advance health. We believe this will result in better health for
community members and help to optimize limited state resources.
These and other targeted initiatives on the social determinants of health are essential
elements and illustrative of our natural and long-standing ESG impact. Our recently
published Sustainability Report captures the full range of efforts we have dedicated
ourselves to in areas of crucial concern to our stakeholders … none more so than
advancing health and health equity. This agenda is an essential part of our way of doing
business.
I would like to thank our 330,000 colleagues from across the company for the passion
and diligence they show every day in helping to deliver improvements in serving our
members, clients and patients.
I have great confidence that we are emerging from the last 18 months of disruption with
an unprecedented set of opportunities to help improve the health system for all of those
we can serve.

-- 3 of 9 --

4
And now I’ll turn it over to President and Chief Operating Officer Dirk McMahon to
provide more detail on initiatives to drive performance across the organization.
Dirk McMahon
Thank you, Andrew.
In an enterprise with our breadth of market engagement, we have many ways to assess
how we’re doing. I’d like to share some of those metrics with you, picking up on
Andrew’s commentary on our three key strategic themes.
First, collaboration. UnitedHealthcare’s value proposition is rooted in lower costs, better
outcomes and a better experience. Optum supports this value proposition for
UnitedHealthcare and other health plans with ambulatory services which patients and
their doctors value.
In this quarter we met the ambulatory surgery needs of over 250,000 patients, delivering
exceptional care in convenient and affordable settings, with revenue growth
approaching 20% over the non-pandemic affected 2019 second quarter. These centers
are meeting higher acuity and more complex needs, such as total joint replacement,
spine and cardiovascular procedures, which are performed at an increasing number of
centers. Our ambulatory settings receive a consumer NPS of 92 and we deliver better
and more consistent quality outcomes at about half the cost of traditional settings.
Optum Care has over 1,600 clinics and is rapidly expanding virtual offerings to serve
patients in settings where they feel the most comfortable … and importantly, with their
own physician. Seniors served by Optum Care under our integrated care approach
spend considerably more time with their primary care physicians than seniors in
traditional Medicare and, as a result, spend one-third fewer days in a hospital.

-- 4 of 9 --

5
Second, is our strategy to increase the application of technology to improve patient care
and help the system run better. We recently announced a partnership with Bassett
Healthcare, another strong example of how OptumInsight is helping health systems to
expand and scale essential capabilities, including revenue cycle management and
digital modernization, to improve health outcomes and patients’ health care
experiences. We expect to continue to add new partnerships like this.
Also, at OptumInsight, we have been tackling the most resource-intensive operations
through the deployment of advanced technology and other approaches. For example,
we have transformed what were once largely manual chart review processes into highly
automated operations.
Third, we have been hard at work advancing our consumer capabilities.
UnitedHealthcare has made significant advances in the management of complex
conditions. We’re focused on making sure that patients with the highest acute care
needs are able to access the most appropriate site of care by assigning them advocates
to help navigate the system. Nearly 1 million of these members are matched with a
personal navigator to help them manage and improve their health.
OptumRx continues to improve access and affordability of home delivery for patients,
leading to significant improvements in continuity of care and having already reduced the
cost to process and dispense prescriptions by nearly 20% in just the past two years.
Also along consumer cost savings lines, for those who prefer an “in-store” retail
experience, we now offer tools to find the lowest cost prescriptions near them
regardless of their health benefits coverage status. These tools can save self-paying
consumers up to 80% on their medications.
Consumer preference is also having an impact in behavioral health. Already this year
the OptumHealth behavioral platform has delivered over 500,000 virtual visits, an option
we initiated in just the last year. Many consumers and clinicians prefer these virtual

-- 5 of 9 --

6
encounters, since they offer enhanced accessibility, flexibility and simplicity. Care
encounters delivered through our dedicated channel have a patient satisfaction of 98%.
These are just a few of the many initiatives we are executing on as we apply
technology, data and analytics to make our strategic growth agenda come alive. We
look forward to updating you on our progress over the quarters to come.
With that, now I’ll turn it over to Chief Financial Officer John Rex.
John Rex
Thank you, Dirk.
Our first half performance supports a foundation for strong and expanding growth for the
remainder of this year and beyond.
Before I review business performance, I’ll offer brief perspectives on the pandemic-
driven trends we’re observing. The core takeaway is that our outlook for COVID-19
impacts is consistent with our past commentary.
The second quarter showed overall care activity continuing to trend toward baseline —
or normalized levels — albeit with variation across lines of business.
For example, in commercial markets, care activity was above baseline as members
were willing and able to obtain needed care, some of which was deferred from prior
periods.
Our public-sector markets continued to run below baseline, even as we are actively
encouraging people to get the care they need. We were gratified to see care activity for
these populations begin to progress over the course of the quarter, as vaccination rates
advanced.

-- 6 of 9 --

7
We continue to estimate approximately $1.80 per share of unfavorable COVID-19
impacts for full year 2021 and to expect the majority of these effects to occur in the
second half.
Moving to overall business performance: OptumHealth’s second quarter revenue and
earnings increased 46% and 34% respectively year-over-year. Revenue per consumer
grew by 43%, reflecting the impact of accountable arrangements and our expanding
home and community health platform, combined with the growing complexity of the
needs we are serving. Of the 20 million patients we serve through Optum Care, over
2 million are in fully accountable — or capitated — care arrangements, an increase of
17% from a year ago and we expect this pacing to accelerate strongly in the years
ahead.
OptumInsight’s revenue grew 12% in the quarter and earnings grew 36%, with the
revenue backlog increasing by $1.9 billion to $21.3 billion. Key growth drivers were
managed services, the continued recovery of care activity to more normal levels and
further implementations of technology-enabled services. In particular, we are seeing
strong sales momentum in the services, software and analytics businesses which serve
care providers.
OptumRx revenue and earnings increased 5% and 19% year-over-year and script
growth was 8%, with this comparison impacted by last year’s pandemic effected care
patterns. Our expanding pharmacy care and specialty services continue to grow
strongly, now comprising just under half of OptumRx revenues.
Turning to UnitedHealthcare, we are encouraged by the receptivity to our expanding set
of responsive commercial benefits, centered around virtual-first, on-demand and
physician-led offerings. Year-to-date we have added about 150,000 members in such
innovative commercial offerings, even with the evolving and uneven labor market trends
which impacted second quarter membership.

-- 7 of 9 --

8
Medicare Advantage membership has grown by 675,000 year-to-date, tracking well to
our full year outlook. Our HouseCalls clinicians have been able to provide their vital
services to seniors, conducting over 1.1 million home visits in the first half, more than
double the year ago level.
People served in managed Medicaid programs grew by nearly 920,000 over the year-
ago quarter, in part as state-based redetermination activities remained on hold. Our
Medicaid offerings continue to deliver a positive consumer experience and
demonstrable cost-effectiveness for our state government partners and we look for this
momentum to build heading into next year.
Our liquidity and capital positions remain strong with second quarter cash flows from
operations at $5.5 billion, or 1.3 times net income and we ended the quarter with a debt-
to-capital ratio of 40%. And in early June, our board of directors increased the dividend
by 16%.
As noted earlier, given the strength of our business performance, we’ve updated our full
year adjusted earnings per share outlook to a range of $18.30 to $18.80 per share,
inclusive of the COVID-19 impact incorporated into our full year view. Within this, we
expect the pacing through the second half to be fairly level.
Now I’ll turn it back to Andrew.
Andrew Witty
Thanks, John.
What we tried to provide you this quarter, as we do each time, is a sense not only of
what UnitedHealth Group’s results are, but how we achieve them. The examples we
referenced and countless others throughout this enterprise, along with the consistent

-- 8 of 9 --

9
execution by our colleagues, are what underpin our confidence in our long-term, 13% to
16% EPS growth rate target … and in our ability to help people live healthier lives and
help the health system work better for everyone over the years to come.

-- 9 of 9 --